| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Shiferman Gregory L. | SVP and General Counsel | C/O VOYAGER THERAPEUTICS, INC., 75 HAYDEN AVENUE, LEXINGTON | /s/ Gregory L. Shiferman | 08 Jan 2026 | 0002041689 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VYGR | Stock Option (Right to Buy) | Award | $0 | +100,000 | $0.000000 | 100,000 | 06 Jan 2026 | Common Stock | 100,000 | $4.02 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | This stock option was granted pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan. |
| F2 | The vesting commencement date of the option is the grant date. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee. |